Abbott's lingo™ continuous glucose monitor for health and wellness now available in the u.s.

Designed for people interested in improving their overall health and wellness provides real-time glucose data and personal coaching insights based on the body's reaction to nutrition, exercise and life's daily stressors available without a prescription; explore different purchase options at www.hellolingo.com   abbott park, ill., sept. 5, 2024 /prnewswire/ -- abbott (nyse: abt) today announced u.s. availability of lingo™, the company's first continuous glucose monitoring system available without a prescription.
ABT Ratings Summary
ABT Quant Ranking